Blood Thinners and AMD Hemorrhages

Blood Thinners and AMD Hemorrhages
Many seniors take blood thinners for various types of cardiovascular and other vascular disease as a preventative measure for avoiding a heart attack or stroke. This same senior population is also at greatest risk for age related macular degeneration-including wet or hemorrhagic macular degeneration (AMD). Thus, the question of whether taking anticoagulants might be increasing the risk of and progression of AMD is important and reported on in a study published in Ophthalmology . The results showed that taking anti-platelet or anticoagulant medication was not significantly associated with macular hemorrhage and increased AMD risk unless the patient also had hypertension.

If you or someone you know is taking blood thinners and at risk for age related macular degeneration (AMD) please call us at 508-730-2020, visit Center for Sight, Google+ or www.facebook.com/centerforsightfallriver to schedule an appointment.

Lower AMD Risk with Cholesterol Medication?

Statin Cholesterol Medications & Macular Degeneration

Age Related Macular Degeneration (AMD) continues to be a leading cause of vision loss in seniors-especially those with a family history or other risk factors such as smoking and other forms of vascular disease. While we have progressed a very long way in the treatment of Wet AMD through the use of anti-VEGF therapeutic injections such as Lucentis® and Eylea® , we are always hoping to find additional medications, vitamins or supplements that might be useful in preventing or delaying senior vision loss. There have been a number of clinical studies and reports about whether the use of the cholesterol lowering medications called “statins” are helpful in preventing or delaying AMD. Common statins include Lipitor®, Crestor®, Zocor®, Mevacor® and Pravachol®. Unfortunately, the most recent information we reviewed in a study reported in the Ophthalmology evaluated the association of statin use with progression of age-related macular degeneration (AMD) and found that statin use was not statistically significantly associated with the progression of  AMD and showed no evidence of a beneficial effect on slowing AMD progression.

As with many eye problems, conditions and diseases, age related macular degeneration (AMD) can be best addressed with early detection, diagnosis and treatment.

If you or some you know is concerned about age related macular degeneration (AMD) and has not had a comprehensive eye exam please call us at 508-730-2020, visit Center for Sight, Google+ or www.facebook.com/centerforsightfallriver to schedule an appointment. Center for Sight is conveniently located at 1565 North Main Street, Suite 406, Fall River, Massachusetts 02720 for patients from Massachusetts or Rhode Island. 

Macular Degeneration Biomarker

Age Related Macular Degeneration (AMD) continues to be a leading cause of vision loss for seniors. The most effective way to avoid vision loss is through early detection, diagnosis and treatment. Now, researchers have found a functional “biomarker” that can help predict which patients might have a greater risk for developing age related macular degeneration (AMD). Dark adaptation refers to the time it takes for a person’s eyes to adjust to darkness after being exposed to bright light. The process of “dark adaptation” appears to be a predictor so that patients over 60 years of age who have slowed “dark adaptation” times are telling us that they are at greater risk. In fact according to a National Institute on Aging study of adults age 60 or older, those whose eyes are slow to adjust to the dark have a 2x greater risk of developing age related macular degeneration.

If you or someone you know is over 50, especially if they have increased risk factors for age related macular degeneration such as being a smoker, a family history, diabetes or other vascular disease please call us at 508-730-2020, visit Center for Sight, Google+ or www.facebook.com/centerforsightfallriver to schedule an appointment. Center for Sight is conveniently located at 1565 North Main Street, Suite 406, Fall River, Massachusetts 02720 for patients from Massachusetts or Rhode Island.

Supplements Lower Macular Degeneration Risk Supplements Lower Macular Degeneration Risk

Supplements Lower Macular Degeneration Risk
Age Related Macular Degeneration (AMD) is a very common senior eye problem and in fact is the most common cause of visual loss after the age of 65. AMD affects the cells in the center of the retina-the macula-which contains the majority of photoreceptors responsible for crisp clear vision. Drusen are deposits in the retina that can cause the macula to deteriorate and degenerate and may predispose you to AMD and allow for potentially undesirable new blood vessel growth in the macula. Research shows that antioxidants neutralize drusen and prophylactic treatment of drusen maculopathy with high doses of antioxidants such as vitamins C and E, lutein, zeaxanthin and zinc, used in the recommended forms and doses from the Age-Related Eye Disease Study 2 (AREDS 2). Can lower the risk of developing advanced AMD was reduced by 27% over a 10 year period.

If you are concerned about senior eye health and specifically AMD, when you visit us for your annual eye exam, we will discuss whether in your particular case taking supplements might be beneficial to preserve your eye health and vision. If you have not had a recent eye exam please call us at 508-730-2020, visit Center for Sight, Google+ or www.facebook.com/centerforsightfallriver to schedule an appointment.

Center for Sight is conveniently located at 1565 North Main Street, Suite 406, Fall River, Massachusetts 02720 for patients from Massachusetts or Rhode Island.